![David Martin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Martin
Fondateur chez
AvidBiotics Corp.
Profil
David W.
Martin is the founder of AvidBiotics Corp., founded in 2005, where the title held is Chief Executive Officer & Director.
Dr. Martin was the founder of EOS Biotechnology, Inc., founded in 1997, where the title held was President & Chief Executive Officer in 2003.
Dr. Martin is also the founder of Pylum Biosciences, Inc.,Xyphos Biosciences, Inc...
Former jobs include President & Chief Executive Officer at Lynx Therapeutics, Inc. from 1995 to 1996; Chairman & Chief Executive Officer at GangaGen, Inc. in 2004; Director at Cubist Pharmaceuticals LLC from 1997 to 2009; Lead Director at Varian Medical Systems, Inc. from 2010 to 2012; Senior Vice President-Research & Development at Genentech, Inc. in 1990; Executive Vice President-Research & Development at DuPont Merck Pharmaceutical Co. in 1993; President at Chiron Therapeutics, Inc. in 1995; and Professor at Howard Hughes Medical Institute, Inc., The University of California, San Francisco, the University of California, Hastings, and Duke University School of Medicine.
Education includes a doctorate degree from Duke University.
Postes actifs de David Martin
| Sociétés | Poste | Début |
|---|---|---|
AvidBiotics Corp.
 AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology Develops non-antibody proteins as targeted therapeutics against bacteria, viral infections and cancer | Fondateur | 01/01/2005 |
Pylum Biosciences, Inc.
 Pylum Biosciences, Inc. BiotechnologyHealth Technology Develops avidocin platform technology capable of generating bactericidal protein complexes | Fondateur | - |
Xyphos Biosciences, Inc.
 Xyphos Biosciences, Inc. BiotechnologyHealth Technology Engages in biotechnology business | Fondateur | - |
Anciens postes connus de David Martin
| Sociétés | Poste | Fin |
|---|---|---|
| CUBIST PHARMACEUTICALS INC | Directeur/Membre du Conseil | 04/06/2009 |
GangaGen, Inc.
 GangaGen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel antibacterial proteins targeting infectious diseases | Directeur Général | 01/01/2004 |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Directeur Général | 01/04/2003 |
Lynx Therapeutics, Inc.
 Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | President | 01/01/1996 |
Chiron Therapeutics, Inc. | President | 01/01/1995 |
Formation de David Martin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Varian Medical Systems, Inc.
 Varian Medical Systems, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and supplies radiotherapy medical devices for treating cancer & develops related software solutions | Health Technology |
GangaGen, Inc.
GangaGen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel antibacterial proteins targeting infectious diseases | Health Technology |
AvidBiotics Corp.
AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology Develops non-antibody proteins as targeted therapeutics against bacteria, viral infections and cancer | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Health Technology |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Health Technology |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Hastings
 University of California, Hastings Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chiron Therapeutics, Inc. | |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pylum Biosciences, Inc.
Pylum Biosciences, Inc. BiotechnologyHealth Technology Develops avidocin platform technology capable of generating bactericidal protein complexes | Health Technology |
Xyphos Biosciences, Inc.
Xyphos Biosciences, Inc. BiotechnologyHealth Technology Engages in biotechnology business | Health Technology |
